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Oocyte development in the mammalian ovary requires productive interactions with somatic granulosa cells of the ovarian follicle. Proliferating
granulosa cells support the progression of follicular growth and maturation, multiplying dramatically as it unfolds. The cell cycle recruitment of
granulosa cells is regulated at least in part by hormones such as follicle-stimulating hormone (FSH) and estrogen. Follicles recruited into the
growth phase following formation of multiple layers of granulosa cells have two major fates: either to continue proliferation followed by
differentiation, or to die by programmed cell death, or atresia. While many of the signaling pathways orchestrating ovarian follicle development
are known, the downstream transcriptional regulators that integrate such signals in the mammalian ovary remain to be defined. Recent experiments
in diverse organisms have revealed multiple instances of gonad-selective components of the basal transcriptional machinery. One such protein,
TAF4b, is a gonadal-enriched coactivator subunit of the TFIID complex required for normal female fertility in the mouse. To determine the
etiology of female infertility of the TAF4b-deficient mice, we have determined multiple functions of TAF4b during postnatal ovarian follicle
development. Here we demonstrate that the TAF4b protein is expressed in the granulosa cell compartment of the mammalian ovarian follicle.
Furthermore, TAF4b-deficient mouse ovaries contain reduced numbers of primordial as well as growing follicles and a concomitant increased
proportion of apoptotic follicles in comparison to wild type counterparts. Importantly, TAF4b-null follicles are largely resistant to induction of
proliferation in response to multiple hormonal stimuli including estrogen and FSH and demonstrate compromised granulosa cell survival.
Together, these data suggest that TAF4b integrates a program of granulosa cell gene expression required for normal ovarian follicle survival and
proliferation in response to diverse ovarian signaling events.
© 2006 Elsevier Inc. All rights reserved.Keywords: Folliculogenesis; Granulosa cells; TAF4b; TFIID; Survival; Proliferation; AtresiaIntroduction
Growth and development of a mammalian oocyte takes place
in a specialized compartment of the ovary called the ovarian
follicle. These follicles are comprised of multiple cell types: a
single germ cell (oocyte) surrounded by multiple layers of
somatic granulosa cells, which in turn are enveloped by thecal
cells. Follicle growth and oocyte development are closely
regulated by an ordered and complex series of signaling events
occurring during folliculogenesis. A succession of linked⁎ Corresponding author. Fax: +1 401 863 2421.
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doi:10.1016/j.ydbio.2006.12.011paracrine and endocrine hormonal signals (such as c-Kit,
GDF9, FSH, and LH) direct postnatal mammalian follicle
development from the initial events of primordial follicle
recruitment to ovulation of a mature oocyte decorated with
cumulus granulosa cells (reviewed in Matzuk and Lamb, 2002).
These irreversible, forward developmental transitions are
balanced with the controlled culling of many follicles by
regulated follicle death called atresia. Elucidating mechanisms
that regulate follicle selection for growth versus atresia is critical
for understanding the normal developmental processes occur-
ring during folliculogenesis. While numerous signaling path-
ways have been shown to be essential for the precise regulation
of folliculogenesis and preventing premature ovarian failure
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changes in gene expression patterns underlying the execution
of these developmental transitions are largely unknown.
To address the molecular mechanisms underlying female
fertility and folliculogenesis, we have begun to characterize the
ovarian functions of a gonadal-enriched subunit of the TFIID
complex, called TAF4b (formerly TAFII105). In eukaryotes,
activation of gene transcription results from the combinatorial
input of activator proteins and multi-protein co-activator
complexes that respond to specific signaling networks (reviewed
in Lemon and Tjian, 2000; Taatjes et al., 2004). TFIID is a multi-
protein general transcription factor complex that is largely
conserved from yeast to humans and is a central player in the
activator-dependent recruitment of RNA polymerase II (Pol. II)
to specific gene promoters (reviewed in Albright and Tjian,
2000). Rather than directly binding to Pol. II, transcriptional
activators utilize a set of diverse coactivators and general
transcription factors to guide Pol. II to specific genes. The TFIID
complex contains the TATA-box binding protein (TBP) and
approximately 14 TBP-associated factors serving as coactivators
(TAFs; reviewed in Matangkasombut et al., 2004). Studies in
yeast have confirmed the critical role of TAF subunits in
recruitment of Pol. II for transcriptional activation (Komarnitsky
et al., 1999). In metazoans, the broadly expressed transcriptional
activator Specificity Protein 1 (Sp1) has been shown to
specifically interact with dTAF4 (formerly Drosophila
TAFII110) and hTAF4 (formerly human TAFII130) subunits of
TFIID complex in Drosophila and mammals respectively (Hoey
et al., 1993; Gill et al., 1994; Tanese et al., 1996; Saluja et al.,
1998). Until recently, the regulation of tissue-specific gene
expression was mostly attributed to activator proteins that may
interact with TAFs and can be expressed in precise cell type-
specific patterns. However, recent biochemical and genetic
studies suggest that certain members of the basal transcriptional
machinery are in fact expressed in a tissue-specific manner and
contribute to tissue-selective gene expression patterns (reviewed
in Hochheimer and Tjian, 2003; Levine and Tjian, 2003).
Diversification of general transcription factors has been
employed in metazoans to regulate gonadal gene expression
patterns and reproduction (reviewed in DeJong, 2006). The most
notable examples are gonad-selective subunits of TFIID that are
critical for reproduction in species as diverse as Drosophila and
mice (Hiller et al., 2001; Martianov et al., 2001; Zhang et al.,
2001; Hiller et al., 2004). In addition, a testis-specific subunit of
TFIIA, called ALF, has been found selectively expressed in
mouse germ cells (Upadhyaya et al., 2002). Accordingly, gene
expression patterns required for sexual reproduction appear to be
executed in part by gonadal forms of core transcription
regulatory factors. However, the cellular functions and mole-
cular mechanisms executed by these variant basal transcription
factors in the gonads remain poorly understood.
To directly elucidate transcriptional mechanisms operating in
the mammalian ovary, we have begun to delineate the in vivo
functions of TAF4b in female reproduction. This work was
initiated by the discovery that viable and apparently healthy
TAF4b-deficient female mice were infertile owing to gross
developmental defects of the ovary (Freiman et al., 2001).Recently, we demonstrated the ability of TAF4b to modulate
networks of granulosa cell gene expression and siRNA knock-
down of TAF4b levels in cultured granulosa cells was shown to
disrupt normal granulosa cell morphology (Geles et al., 2006).
Together, these studies provide the framework for the potential
mechanism of TAF4b as an integrator of ovarian gene
expression underlying granulosa cell functions required for
robust female fertility.
In the present study, we have elucidated the sub-ovarian
expression and function of TAF4b in the postnatal ovary. We
show that TAF4b protein is readily detected within the
granulosa cell compartment of the mouse ovary. Morphometric
analysis of TAF4b-deficient ovaries indicates that TAF4b is
required for multiple aspects of folliculogenesis. These include
early primordial follicle survival as well as subsequent follicle
growth. Most importantly, TAF4b-deficient granulosa cells are
significantly impaired in their ability to proliferate in response
to multiple hormonal stimuli in vivo. TAF4b-deficient granu-
losa cells undergo increased apoptosis and TAF4b-deficient
follicles display increased rates of atresia. Together, these
studies suggest that TAF4b is required for the normal in vivo
response to hormonal signaling in the ovary supporting
granulosa cell survival and proliferation during folliculogenesis.
Materials and methods
Animals
Wild-type and TAF4b-null mice were generated by mating heterozygous
TAF4b+/−male and female mice as previously described (Freiman et al., 2001).
Offspring were genotyped by PCR analysis of tail-snip genomic DNA
amplifying the region targeted by homologous recombination. All animal
protocols were reviewed and approved by Brown University institutional animal
care and use committee and were performed in accordance with the NIH Guide
for the Care and Use of Laboratory Animals.
Generation of anti-mouse TAF4b antibodies
A fragment encompassing an amino-terminal variable domain of mouse
TAF4b (amino acids 2–98) was expressed in Escherichia coli as a GST-tagged
fusion protein and used as immunogen to generate a rabbit polyclonal serum (as
per standard procedure; Harlow and Lane, 1999). For affinity purification of the
specific anti-TAF4b antibodies, we generated a 6XHis-tagged fusion construct
with the same domain of the protein. The expression construct was transformed
into SG130009 strain of E. coli, and induced to express the fusion proteins with
1 mM IPTG for 3 h at 37 °C. The cells were harvested, resuspended in the
denaturing lysis buffer (8 M urea, 100 mM NaCl, 20 mM Hepes pH 8.0), and
lysed by rapid freeze–thaw followed by sonication. Insoluble fractions were
removed by centrifugation at 10,000×g for 10 min. The supernatants containing
fusion proteins were bound to Ni-NTA resin (ProBond, Invitrogen, Carlsbad,
CA), and washed with 20 mM imidazol-containing wash buffer. The bound
proteins were eluted with increasing concentrations of imidazole (stepwise:
100 mM, 250 mM, 500 mM, and 1 M), the majority of protein eluted with
250 mM imidazole fraction. The purified protein was crosslinked to Affigel 10
matrix as per manufacturer's protocol (Bio-Rad, Hercules, CA), and the specific
antibodies were purified by sequential binding and eluting of the antibody as per
the manufacturer's protocol.
Purified granulosa cell isolation
The ovaries of 8-week-old wild type C57/Bl6 mice (Jackson Laboratories,
Bar Harbor, ME) were removed and subjected to puncture with a 26 gauge needle
to liberate granulosa cells into collection media (DME-F12, 1× penicillin–
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through 40 μm nylon filter to remove large tissue clumps and oocytes. The
granulosa cell-depleted residual ovarian tissue (termed “ovary remnants” here)
was washed in PBS and dounced in low salt protein extraction buffer. Purified
granulosa cells were spun down, washed in PBS, spun down again, and resus-
pended in extraction buffer. For total ovary extracts, whole ovaries were dounced
in low salt extraction buffer. The resultant extracts were analyzed by western
blotting using our affinity-purified anti-TAF4b antibodies.
Morphometric analysis of ovarian follicles
9 μm sections of paraffin-embedded ovaries were fixed in 3.7%
formaldehyde and mounted on slides. Routine hematoxylin and eosin staining
was performed for histologic examination by light microscopy. The number of
follicles for each ovary was counted in 10–15 consecutive largest sections; only
follicles with visible oocyte nuclei were counted. Follicles were classified as
primordial, primary (surrounded by a single layer of cubiodal granulosa cells),
growing preantral (oocytes surrounded by two or more layers of granulosa cells
with no antrum), or antral (antrum within the granulosa cells enclosing the
oocyte). Follicles were determined to be atretic if the oocyte and/or granulosa cell
exhibited pyknotic nuclei and cytoplasmic shrinking, or granulosa cells were
pulling away from the basement membrane. Average number of follicles per
section was determined for each follicle type in each animal. Data is presented as
average±S.E.M. from at least 3 pairs ofmice for each time point (Hu et al., 2004).
Stat3 immunocytochemistry
Stat3 staining was performed as described (Murphy et al., 2005). Sections
derived as above were subjected to a microwave antigen retrieval technique by
heating for 5 min in 10 mM citrate buffer (pH 6.0). The cooled sections were
incubated in 3% H2O2 for 5 min to quench endogenous peroxidase activity,
washed in PBS, and blocked in PBS/0.5% Tween-20 with 10% normal goat
serum and 10 mg/ml BSA. Sections were then incubated with anti-Stat3 (1:500;
C-20 from Santa Cruz Biotechnology, Santa Cruz, CA) in blocking solution
overnight at 4 °C. Secondary antibody was Goat anti-Rabbit HRP-conjugated
from Pierce (Rockford, IL) applied at 1:300 for 2 h at room temperature.
Sections were developed with 3,3′-DAB (Vector kit), lightly counterstained with
hematoxylin, dehydrated, and mounted with Permount (Fisher). Follicles were
quantified as above.
BrdU incorporation
Assessment of granulosa cell proliferation by BrdU incorporation was
performed as previously described by Kadakia et al. (2001). Hormonally primed
mice (5 IU PMSG or 1 μg/g E2 for 24 h) were injected i.p. with 1 μg/gm BrdU,
and sacrificed after 1 h. The ovaries were dissected, frozen in OCT, and 7 μm
frozen sections were generated. The sections were rinsed in CSK buffer (10 mM
Hepes pH 7.4, 300 mM sucrose, 100 mM NaCl, 3 mM MgCl2) once at room
temperature, incubated in CSK/Tx-100 (0.5%) buffer for 2 min on ice, and fixed
in 100% methanol at −20 °C for 20 min. The DNAwas denatured by incubation
in 2N HCl for 90 min at room temperature, and the slides were neutralized by
rinsing 2× w/PBS. Endogenous peroxidase activity was quenched by incubating
in 3% H2O2 for 5 min. The slides were further washed in PBS, and blocked in
PBS/0.5% Tween-20 with 10% normal goat serum and 10 mg/ml BSA for
20 min followed by blocking with PBST supplemented with 200 ug/ml
unlabeled goat anti-mouse Fab fragments (to decrease the secondary antibody
background). Primary monoclonal anti-BrdU antibody was used at 1:100
dilution; the remaining procedures were carried out as described above. After
counterstaining with hematoxylin, the percentages of positive cells per follicle
were determined for comparison in 5 follicles per each experimental animal.
Preantral follicles were analyzed in the estrogen-treated animals; in the PMSG-
treated group, antral follicles induced by hormonal treatment in wild-type and
heterozygous animals were included into the analysis as well.
PCNA immunolabeling
Chromatin recruitment of PCNAwas assessed as in van Betteraey-Nikoleit
et al. (2003), with modifications. Frozen sections were rinsed in cold CSK bufferonce, incubated in CSK/Tx-100 (0.5%) buffer for 2 min on ice, and fixed in
100% methanol at −20 °C for 5 min. Peroxidase quenching, blocking and
labeling procedures were as described for BrdU immunolabeling. Primary anti-
PCNA monoclonal antibody (PC-10) was used at 1:100 dilution.
Histone H3AcK9 immunolabeling
Frozen sections of the ovaries were fixed in 3.7% formaldehyde. Peroxidase
quenching, blocking and labeling procedures were as above. The primary
antibody against Histone H3 acetylated on K9 was obtained from Upstate
Biotech (Lake Placid, NY), and used at 1:200 dilution.
Caspase-3 immunolabeling
Granulosa cell apoptosis was assessed in frozen ovarian sections (Matikainen
et al., 2001). Frozen ovarian sections of estrogen-primed mice fixed in methanol
were labeled with rabbit monoclonal antibodies against cleaved caspase-3 (5A1)
and against total caspase-3 (8G10), which were obtained from Cell Signaling
Technology (Danvers, MA) and used at 1:300 and 1:100 dilution respectively.
Secondary goat anti-rabbit Cy-3 conjugated antibodywas from JacksonResearch
Laboratories (Westgrove, PA), and used at 1:300 dilution.
TUNEL assay
DNA fragmentation associated with apoptosis was assessed in frozen
sections of the estrogen-primed mouse ovaries fixed with 3.7% formaldehyde
using ApoAlert DNA fragmentation kit (BD Biosciences Clontech; San Jose,
CA) as per manufacturer's protocol.
Quantitative PCR
Total RNA was isolated from whole ovaries of the untreated 17-week-old
mice using Qiagen RNeasy mini kits, or from the ovaries of estrogen-primed 3-
week-old mice using Qiagen RNeasy micro kit. 20 μl of cDNA was prepared
from approximately 1 μg of total RNA using iScript cDNA Synthesis Kit (Bio-
Rad Laboratories, Hercules, CA) according to manufacturers directions, using a
mix of oligo(dT) and random primers. Real-time PCR reactions were performed
in triplicate using 2 μl cDNA template, ABI SYBR green PCR master-mix and
primers for Esr2, Fshr and 18S rRNA in ABI 7300 Real Time PCR System.
Relative expression levels of Esr2 and Fshr were normalized to 18S ribosomal
RNA levels to correct for equivalent total RNA levels.
Primer sequences are as follows:
18S F-ccgcggttctattttgttgg
Esr2 F-aaacagagagaccctgaagagaa
Fshr F-ccaacctacccaacttgcatg
18S R-ggccgtccctcttaatcatg
Esr2 R-cctcttggcgcttggactag
Fshr R-cagatatcggagactgggaagatt
Serum hormone levels
FSH, LH, and prolactin in 6-week-old female mice were measured by
radioimmunoassay using reagents from the National Hormone and Pituitary
Program (Harbor-UCLAMedical Center, Torrance, CA). Nine to twelve animals
were analyzed per genotype.
Results
Expression of TAF4b in the granulosa cells of the ovarian
follicle
To determine the cell types and cellular processes affected by
TAF4b gene disruption in the TAF4b-null female mice, we
examined the expression pattern of the TAF4b protein in
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expression of TAF4b protein, we generated polyclonal antisera
raised against the hypervariable domain of mouse TAF4b
compared to TAF4 (first 98 amino acid residues) fused to GST.
The crude antisera specifically detects TAF4b, but not TAF4 by
Western blot analysis (data not shown). Affinity-purified anti-
TAF4b antibodies show that similar to its mRNA expression in
adult mouse tissues, TAF4b protein is most readily detected in
the testis and ovary (Fig. 1A). To test whether TAF4b is enriched
in a specific cell type within the ovary, we examined the
expression of TAF4b protein in ovarian granulosa cells. We
found TAF4b enriched in purified granulosa cells of the adult
ovary and, conversely, depleted in ovarian remnants after
granulosa cell expulsion (Fig. 1B), in agreement with our
previously reported mRNA expression pattern (Freiman et al.,
2001). The TAF4b enrichment in granulosa cells is even more
pronounced than that of cyclin D2, an established granulosa cell-
expressed cell cycle protein (Sicinski et al., 1996). Finally,
immunolabeling detected TAF4b-positive granulosa cells in
preantral follicles derived from actively cycling mice at
12 weeks of age (Fig. 1C); in contrast, granulosa cells of early
preantral follicles appeared negative for TAF4b protein expres-Fig. 1. TAF4b protein is enriched in ovarian granulosa cells. (A) Western blot of mo
levels serve as a loading control. (B) TAF4b is enriched in purified granulosa cells, a
ovary protein extract represents starting material without fractionation. Cyclin D2 i
control. (C) TAF4b immunolabeling in 12-week-old mouse ovary detects protein ex
granulosa cells of early preantral follicles are not labeled (*). (D) Granulosa cell lab
cytoplasmic stromal-cell labeling has been determined to be non-specific. All follic
Western blot indicates absence of full-length TAF4b from ovary extracts of TAF4b-sion. This granulosa cell labeling appeared specific since such
late preantral follicle immunostaining was not detected in the
TAF4b-null ovaries (Fig. 1D) as opposed to general stromal cell
background. Furthermore, the full-length TAF4b-specific band
is not detected in the TAF4b-null ovarian extract by western blot
analysis (Fig. 1E). We conclude that in adult female mice,
TAF4b is readily detected in follicular granulosa cells and that
the reproductive defects stemming from disruption of TAF4b
may be in part due to disruption of normal pathways regulating
gene expression in granulosa cells. A recent report has found
TAF4b protein expressed in the oocytes of embryonic and
prepubertal mice, suggesting a more dynamic regulation of the
TAF4b expression pattern in the ovary (Falender et al., 2005).
However, the focus of the present study is to examine the
potential functions of TAF4b in the granulosa cell compartment
of the ovary.
Multiple defects in ovarian folliculogenesis in the TAF4b-null
ovaries
TAF4b-null female mice are infertile, at least partially due to
defective follicular development. To determine if a particularuse tissue extracts (∼20 μg/lane) probed with anti-TAF4b antibodies; β-tubulin
s opposed to ovary remnants depleted of granulosa cells (ovary remnants). Total
s a granulosa cell-enriched cell cycle protein and β-tubulin serves as a loading
pression in granulosa cells of selective large preantral follicles (arrows), while
eling is absent from the large preantral follicles of TAF4b-null females (*); the
les in panels C and D are preantral; size bar in panel D indicates 100 μm. (E)
null mice, *denotes non-specific cross-reacting bands.
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mice, we characterized ovarian follicles in these animals
compared to fertile littermates during the transition from
prepubertal to adult ovarian development. Here, we determined
follicle composition in the TAF4b-null ovaries as compared to
their wild-type and heterozygous littermates at different ages of
development. For quantification, we utilized histologicalFig. 2. Morphometric analysis of TAF4b-null ovarian follicles. (A–D) Represen
hematoxylin–eosin (A–B) or with anti-stat3 antibodies and hematoxylin (C–D). A: p
TAF4b-null ovary. C: clusters of primordial oocytes are detected by Stat3 label in a wi
follicles are found in a TAF4b-null ovary. Size bar in panel A indicates 100 μm. (E–I
numbers of follicles of each indicated type per section at the ages analyzed. Error bars
significantly different from wild type numbers (p<0.05) are indicated with asterisk
follicles; I: atretic follicles.sections of the ovaries stained with hematoxylin and eosin (H
and E; Figs. 2A–B), or for efficient identification of primordial
follicles, we used ovary sections stained with anti-Stat3
antibodies, which highlight oocytes (Murphy et al., 2005),
and counter-stained with hematoxylin (Figs. 2C–D). Morpho-
metric analysis of follicular distribution across development
was performed at postnatal days 21, 45, and 84, providing atative sections of 21-day-old wild type or TAF4b-null ovaries stained with
reantral follicles in the wild-type ovary. B: many atretic follicles (arrows) in the
ld-type ovary (marked with asterisk, and enlarged in inset). D: atretic and primary
) Dynamics of follicle types across different mouse ages. Bars represent average
indicate S.E.M.; 3–5 mice were analyzed per each time point. TAF4b-null values
s. E: primordial follicles; F: primary follicles; G: preantral follicles; H: antral
720 E. Voronina et al. / Developmental Biology 303 (2007) 715–726global overview of follicle populations before, during, and after
sexual maturation. The numbers of preantral follicles in TAF4b-
null mice were significantly lower than in controls (Fig. 2G),
suggesting that these either arise from primary follicles at a
lower rate due to insufficient proliferation of granulosa cells, or
that they are lost due to attrition by apoptosis. Unexpectedly, we
also found reduced numbers of primordial follicles in TAF4b-
null mice compared to their wild-type and heterozygous
littermates (Fig. 2E). In spite of the low numbers of primordial
follicles as early as 3 weeks of age, the decrease in primary
follicles numbers in TAF4b-null mice was never statistically
significant, suggesting similar rates of follicular recruitment into
the growing (preantral) phase. The antral follicles of the TAF4b-
null mice increase in numbers slowly up to 6 weeks of age, but
decline at 12 weeks due to depletion in the primordial and
growing oocytes reserves. Collectively, this analysis suggests
that TAF4b-deficiency leads to multiple defects throughout
folliculogenesis, rather than disruption of a single develop-
mental transition or event.
TAF4b promotes granulosa cell proliferation in vivo
To better understand the cellular basis of the observed
folliculogenesis defects in the TAF4b-deficient ovaries, we
assessed the proliferation of granulosa cells in the presence
versus absence of TAF4b. Bromodeoxyuridine (BrdU) incor-
poration in vivo was utilized to directly label granulosa cells in
the S-phase of the cell cycle and measure granulosa cell
proliferation. Twenty-four hours prior to BrdU labeling,
matched 21-day-old TAF4b-null and wild-type or heterozygous
female mice were stimulated with a single injection of either
estrogen (Kadakia et al., 2001) or PMSG (Robker and Richards,
1998) to stimulate proliferation of follicular granulosa cells.
Ovaries were harvested the next day following 1 h in vivo BrdU
treatment, and ovary sections generated from these mice were
labeled with anti-BrdU antibodies. BrdU incorporation was
readily detectable in granulosa cells derived from wild-type or
heterozygous mice (Figs. 3A, C) and significantly reduced in
the TAF4b-null ovaries in response to both hormonal treatments
(Figs. 3B, D, G). PCNA chromatin recruitment was used as an
alternative marker of S-phase progression in these hormonally
primed mice, and similarly indicated a decreased number of
proliferating granulosa cells in TAF4b-null ovaries (Figs.
3E–G). Control immunolabeling of acetylated histone H3 (on
lysine 9) stained granulosa cell nuclei of each genotypeFig. 3. Granulosa cell proliferation defects in the TAF4b-null ovaries. (A–D)
BrdU incorporation into the nuclei of follicular granulosa cells in 4-week-old
TAF4b-heterozygous (left column) and null (right column) mice was assessed
by immunolabeling. (A–B) Mice stimulated with 5 IU PMSG for 24 h. (C–D)
Mice stimulated with 1 μg/g estrogen for 24 h. (E–F) PCNA immunolocaliza-
tion in TAF4b heterozygous (F) or null (G) ovaries detects fewer PCNA-positive
nuclei in the null follicles after estrogen stimulation. (G) Quantification of
percent positive nuclei in follicles in the experiments in panels A–F. Average
values from two independent experiments are presented; error bars indicate
S.E.M. Statistically significant differences between TAF4b-null mice and
matched controls are indicated with asterisks (p<0.001). (H–I) Control, uniform
immunolabeling with anti-acetylated histone H3 antibody in TAF4b hetero-
zygous (H) or null (I) ovaries. Size bars in the micrographs indicate 100 μm.
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incorporation and PCNA recruitment in the TAF4b-deficient
mice upon hormonal priming are indicative of cell cycle defects
in the granulosa cells that lead to aberrant folliculogenesis
profiles and infertility.
The observed lack of proliferative response to either
gonadotropin or estrogen stimulation suggested that the defect
in granulosa cell cycle progression is downstream of circulating
blood levels of these hormones as well as from levels of their
corresponding seven-transmembrane follicle stimulating hor-Fig. 4. Elevated serum FSH in TAF4b-null mice. (A) Circulating levels of FSH, prola
littermates. Hormonal levels in TAF4b-null mice significantly different from controls
levels of estrogen receptor beta (Esr2) and FSH receptor (Fshr) mRNAs in TAF4b-nu
Fshr mRNA levels are dramatically reduced in TAF4b-null mice (C, E). 18S ribosom
time PCR was performed in triplicate on the total RNA samples from the ovaries of th
(C, E) of age. The Ct values for Esr2 (B, C) and Fshr (D, E) were normalized to 18S r
level. Wild-type expression level values in each experiment were arbitrarily set to 1
3-week-old wild type, TAF4b-null and Het #1 were primed with E2 for 24 h. 3-weemone receptor (Fshr), or nuclear hormone estrogen receptor β
(Esr2). To directly test this hypothesis, we determined the serum
levels of FSH in these mice, and found it to be significantly
elevated in the TAF4b-null mice compared to matched
heterozygous mice (Fig. 4A). In contrast, serum levels of
luteinizing hormone (LH) and prolactin were relatively
equivalent between the two genotypes. The pronounced and
specific increase in FSH in TAF4b-null mice is consistent with
hypogonadal, hypergodanotrophic female infertility seen in
many cases of POF and in mouse models of female infertilityctin, and luteinizing hormone were measured in TAF4b-null mice and in control
are indicated with an asterisk (p<0.001). (B–E) Real-time PCR detects normal
ll ovarian samples at 3 weeks of age (B, D). At 17 weeks of age, both Esr2 and
al RNA levels were used as a control for normalizing the data. Quantitative real-
e wild-type, heterozygous, and TAF4b-null mice at 3 weeks (B, D) or 17 weeks
RNA (ΔCt), and the resultant value was used to calculate the relative expression
, and the remaining values were scaled accordingly. Error bars represent 1 S.D.
k-old Het #2 and all of 17-week-old mice were non-treated.
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2002).
To confirm the correct transcription of these hormone
receptors, we measured the levels of Fshr and Esr-2, mRNAs
in the ovaries of TAF4b-null mice and their littermates by
quantitative real-time rtPCR at several time points (Figs.
4B–E). We found that at 3 weeks of age, when we administer
estrogen and PMSG, TAF4b-null mice displayed no significant
reduction of either mRNA (Figs. 4B, D). In contrast, at
17 weeks of age, when TAF4b-null ovaries have only a few
recognizable follicle structures, levels of both receptors are
decreased compared to wild-type and heterozygous mice (Figs.
4C, E). This reduction could be due to a combination of lower
numbers of granulosa cells in the ovary and a downregulation of
expression of these mRNAs in the remaining granulosa cells.
Together, these data suggest that one of the major limitations of
TAF4b-deficient granulosa cells contributing to the lack of
preantral follicles in the TAF4b-null mice is that these mutant
granulosa cells are incapable of efficient recruitment into
proliferation by either endogenously increased FSH levels, or
by exogenously supplied hormones, despite the apparent
presence of normal levels of corresponding receptors. In
agreement with this conclusion, superovulation regimens
supplementing animals with PMSG and hCG failed to restore
the numbers of pre-ovulatory and ovulation in the TAF4b-
knockout females (Freiman et al., 2001). These data indicate
that at early time points in the absence of TAF4b, ovaries have
lost the capacity to respond to diverse hormonal signaling
events in the presence of relatively normal levels of Fshr and
Esr2 hormone receptors, and suggest that TAF4b is required to
integrate the transcriptional response to hormonal signals.
TAF4b is required for granulosa cell survival
Quantitative analysis of follicular development in the
TAF4b-null mice detected similar numbers of primary follicles
in TAF4b-null and control mice, suggesting that the follicles
enter the preantral growing pool with equivalent efficiency. If
the only defect of TAF4b-null granulosa cells was impaired
proliferation rate, we would expect to see similar numbers of
preantral follicles as in wild type or heterozygous mice;
however, such follicles would be of smaller size. Nevertheless,
we consistently observed reduced numbers of preantral
follicles, despite persistent recruitment of new primary follicles
up to 12 weeks of age (Figs. 2F, G), suggesting that the
observed decline of preantral follicles numbers stems not only
from impaired granulosa cell proliferation, but potentially also
from excessive follicular atresia. In fact, we initially observed
an increase in atretic follicles in histologically stained sections
of the TAF4b-null mice compared to control (Fig. 2I).
To directly analyze follicular atresia on a molecular level we
assessed caspase-3 activation in granulosa cells, which is a
reliable marker of apoptosis in this cell type (Robles et al., 1999;
Matikainen et al., 2001). As our data indicated defective
response of TAF4b-null granulosa cells to hormonal stimula-
tion, we specifically assessed apoptotic events in preantral
follicles following treatment of mice with estrogen. Weimmunostained ovary sections from 3–4-week-old TAF4b-
null and control mice with an anti-caspase-3 fragment antibody
(Figs. 5A–B), which detects a proteolytic product of the
activated caspase-3 indicating progression of the apoptotic
pathway in the cell. This assay detected increased granulosa cell
apoptosis in the preantral follicles of the TAF4b-null ovaries as
compared to a wild type or heterozygous control. Quantification
of positively stained cells in the preantral follicles confirmed a
significant increase of apoptotic cells in TAF4b-null back-
ground (Fig. 5G). As a control, we employed an anti-
procaspase-3 antibody, which is expected to be expressed
ubiquitously in the ovary (Figs. 5C–D). Procaspase-3 staining
was detected uniformly throughout the wild-type ovaries, and
appeared diffuse in the cytoplasm, and granular in the nucleus,
as previously described (Ramuz et al., 2003). Total caspase-3
staining appeared diminished in the TAF4b-null ovaries; this
could be either a general reduction in protein abundance, a
consequence of proteolytic processing of procaspase-3 to the
active enzyme form, or a reduction of caspase-3 mRNA and
protein levels due to increased serum gonadotropin (Flaws et
al., 1995; Boone and Tsang, 1998). To further elucidate the
significance of the increase in caspase-3 activation in the
TAF4b-deficient ovaries, TUNEL assays were performed on the
ovarian sections. This assay similarly detected significantly
increased numbers of apoptotic granulosa cells in the growing
follicles of TAF4b-null mice (Figs. 5E–G). Together, these data
indicate an overall reduction in survival of preantral follicles in
the TAF4b-deficient ovaries and is consistent with the proposed
anti-apoptotic function of TAF4b in B lymphocytes (Yamit-
Hezi et al., 2000; Silkov et al., 2002). Taken together, we
conclude that TAF4b plays a critical role in maintaining the
correct balance between granulosa cell proliferation, survival
and apoptosis that is absolutely required for proper mammalian
ovarian folliculogenesis.
Discussion
Regulation of ovarian-specific gene expression networks in
the mammalian oocyte and surrounding granulosa cells are
necessary for appropriate progression through folliculogenesis.
A number of critical paracrine and endocrine signaling
pathways direct oocyte growth and maturation from primordial
follicle assembly to ovulation in the postnatal ovary (Matzuk
and Lamb, 2002). These highly coordinated developmental
transitions require the integrated function of various somatic
cell types providing the microenvironment, or niche, where
oocytes can grow and mature to become functional gametes.
Granulosa cells which are intimately associated by gap
junction connections with the oocyte in the mammalian
ovary provide the oocyte with essential signals and metabolites
required for oocyte growth and maturation. It is only through
reciprocal signaling events resulting from intimate granulosa
cell–oocyte communication that proper folliculogenesis and
ovulation can be achieved (Matzuk et al., 2002). While many
of the signaling molecules that orchestrate ovarian follicle
progression have been identified, the mechanisms of down-
stream transcriptional integrators that execute the correct
Fig. 5. Increased granulosa cell apoptosis in the TAF4b-null ovaries. (A–B) Activated caspase 3 immunostaining detects increase in the number of atretic follicles in
the 3-week-old TAF4b-null ovary. (C–D) Total caspase 3 immunolabeling detects similar levels of caspase 3 in TAF4b-null and wild type ovaries (C and D are serial
sections corresponding to A and B). Secondary antibody alone generates no detectable signal (data not shown). (E–F) TUNEL assay detects increased apoptosis in the
TAF4b-null ovaries. Control labeling without terminal transferase yield no detectable signal (data not shown). Size bars in the micrographs indicate 100 μm. (G)
Quantification of percent positively stained granulosa cells in experiments in panels A–F. Positive cell counts were performed on growing (preantral) follicles in all
genetic backgrounds. Average values from two independent experiments are presented; error bars indicate S.E.M. Statistically significant differences between TAF4b-
null mice and matched controls are indicated with asterisks (p<0.01).
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to be characterized.
We have identified a transcriptional regulatory protein called
TAF4b that is required for proper folliculogenesis in thepostnatal mouse ovary. TAF4b-deficient female mice are
completely infertile owing to a complex series of ovarian
follicle defects that results in the inability of TAF4b-deficient
mice to produce functional eggs. To begin to understand the
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the postnatal mouse ovary, we have characterized the normal
expression and function of TAF4b in the granulosa cells of the
mouse ovary. Our results are consistent with the notion that
TAF4b integrates a subset of granulosa cell gene expression
networks in response to diverse signaling pathways in the ovary.
In this report, we demonstrate TAF4b protein expression in
granulosa cells by immunostaining wild-type ovarian sections
with affinity-purified anti-TAF4b antibodies, as well as by
Western blot analysis of purified granulosa cell extracts. In
addition to granulosa cell expression, a recent report has
revealed the potential expression of TAF4b in oocytes (Falender
et al., 2005). The difference between the patterns observed
previously and in this study may result from utilization of
different antibodies, fixation conditions, and/or immunostaining
procedures. Alternatively, TAF4b may be expressed in multiple
cell types within the mouse ovary including granulosa cells and
oocytes. Strikingly, TAF4b has been recently found to be
expressed and posttranscriptionally modified in a human
ovarian granulosa cell tumor line (Wu et al., 2005). Following
our detection of TAF4b expression in the granulosa cells, we
then set out to examine the functional significance of TAF4b
during folliculogenesis in the postnatal ovary.
The in-depth analysis of folliculogenesis of TAF4b-null
females before, during, and after sexual maturation described
here reveals a number of related defects that are collectively
associated with the etiology of female infertility observed in
the TAF4b-deficient mice. At 3 weeks of age, immature
TAF4b-null mice display a striking reduction of primordial
follicle pools in comparison to matched heterozygous or wild-
type mice. At present, we cannot distinguish whether this
defect is due to abnormal development of primordial follicles
or to premature culling of these follicles from the ovary by
excessive follicular atresia. In addition to detecting reduction in
primordial follicle numbers, we observed elevated numbers of
atretic follicles and fewer preantral follicles at all time points
examined. This observation suggests that TAF4b-null follicles
may undergo proliferative defects as well as survival defects.
As some TAF4b-null follicles are selected for further
maturation to antral follicles, we conclude that TAF4b
disruption does not result in a complete block of folliculogen-
esis at any single time point. Rather, our data support the
hypothesis that TAF4b-deficient ovaries are defective at
multiple steps required throughout folliculogenesis. This
phenotype may reflect a pleiotropic effect of the loss of a
key gonadal transcription factor, TAF4b, and inability of the
cells to fully and reliably compensate for its absence, even
though a related TAF4 protein is still present. Similarly, TAF4b
itself has been found unable to compensate for TAF4 depletion
in mouse embryonic fibroblasts, suggesting that TFIID
complexes containing only TAF4 may regulate a distinct
though overlapping set of genes than those containing TAF4b
(Mengus et al., 2005). The exact biochemical properties and
mechanistic functions of TAF4b-containing TFIID complexes
still remain to be explored.
Although the number of primordial follicles in the TAF4b-
null mice is reduced, this deficiency is not accompanied by astatistically significant reduction in the number of primary
follicles. This observation is consistent with previous reports
that the number of primordial follicles in the resting pool does
not alter the rate of follicle growth initiation (Hirshfield, 1994;
Ratts et al., 1995; Perez et al., 1999). Prenatal exposure of rats to
a germ cell toxicant busulfan results in a significant reduction of
the oocyte reserve; the treated animals then exhibit a shortened
reproductive lifespan. However, at 3 weeks of age, the ovaries
of such rats contain similar numbers of preantral follicles
compared with controls, even though the primordial follicle
stock is nearly depleted (Hirshfield, 1994). Likewise, genetic
deficiencies reducing the numbers of primordial follicles at
birth, as in the Bcl2-null mice, do not lead to a significant
decrease in the numbers of primordial and preantral follicles
(Ratts et al., 1995). Conversely, genetic manipulations increas-
ing primordial oocyte pool, as in the Bax-null mice, prolong
ovarian lifespan while maintaining similar rates of follicle
recruitment into the growing phase as compared to wild-type
(Perez et al., 1999). Based on these observations, we
hypothesize that the low numbers of preantral follicles in the
TAF4b-null mouse represent an independent deficiency from a
reduction in the primordial follicle pool.
Consistent with this hypothesis, we observe relatively
normal recruitment of the primordial follicles of the TAF4b-
null mice into the growing phase, manifested by normal
numbers of primary follicles. These primary follicles go on to
form preantral follicles, but instead of increasing in size and
forming an antrum, they predominantly undergo atresia. TAF4b
requirement for granulosa cell survival is consistent with the
observed expression of TAF4b-protein in the preantral follicles
of the wild-type mice (Fig. 1C). It is furthermore highlighted by
greater incidence of apoptotic processes in the preantral follicles
of TAF4b-null mice subsequent to estrogen treatment (Fig. 5G)
as compared to wild type controls, where estrogen provides a
pro-survival signal. Collectively, these data suggest that TAF4b
might be a marker for follicular selection, if not simply a
requisite component of the selection pathway. Protection of
granulosa cells from apoptosis is a well-documented conse-
quence of hormonal signaling both in vivo and in vitro (Robles
et al., 1999; Matikainen et al., 2001; Quirk et al., 2006).
Furthermore, increased resistance of the dominant (selected)
follicles to apoptosis is dependent on proliferative response of
their constituent granulosa cells (Quirk et al., 2004). Therefore,
the increased atresia as well as deficient granulosa cell
proliferation observed in TAF4b-null follicles may both be
explained by an aberrant response to hormonal signaling.
Recruitment of cells into the cell cycle is most often regulated
by the accumulation of G1 regulating D-type cyclins. For
example, ovarian granulosa cells depend on expression of cyclin
D2 for normal proliferation in response to FSH (Sicinski et al.,
1996). Strikingly, TAF4b is a regulator of cyclin D2 transcrip-
tion, functioning by directly binding to its core promoter (Geles
et al., 2006). In agreement with this observation, expression of
cyclin D2 mRNA is reduced in the TAF4b-null ovaries (Freiman
et al., 2001). Here, we also detect decreased levels of cyclin D2
protein in ovarian granulosa cells of TAF4b-null ovaries (data
not shown). Together, these data suggest that TAF4b may be part
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of cyclin D2 expression. In addition, we have recently shown c-
Jun to be a direct target of TAF4b regulation in granulosa cells
by promoter recruitment (Geles et al., 2006). C-Jun is an
important regulator of cell proliferation and phospho-c-Jun
expression is reported in the mitotic granulosa cells of preantral
mouse ovarian follicles (Oktay and Oktay, 2004). Given the
potential roles of c-Jun and cyclin D2 in carcinogenesis (Chu et
al., 2002; Eferl and Wagner, 2003; Nateri et al., 2005) and the
role of TAF4b in promoting granulosa cell proliferation
documented here, we speculate that deregulated expression of
TAF4b in the ovary may be associated with subtypes of ovarian
cancer in women, especially during granulosa cell tumorigen-
esis. In fact, a recent report has demonstrated the elevated levels
and posttranslational modifications of TAF4b in a human
granulosa cell tumor line (Wu et al., 2005). Taken together, we
hypothesize that the over-expression of TAF4b in the granulosa
cells of the human ovary may be relevant to the etiology of
granulosa cell tumorigenesis in women.
In addition to defects in proliferation, we observed increased
granulosa cell apoptosis in the TAF4b-deficient ovaries in
comparison to wild-type counterparts. This is consistent with
previously described anti-apoptotic functions of TAF4b in B
and T lymphocytes (Yamit-Hezi et al., 2000; Silkov et al.,
2002). While the precise molecular mechanisms of apoptotic
suppression in granulosa cells remain to be elucidated, it is
likely that TAF4b-containing TFIID complexes specifically
regulate expression of a subset of gene targets involved in
executing the apoptotic pathway. This could be directly through
activator binding and/or promoter recruitment or indirectly
through modulating the expression of a downstream regulator of
apoptosis. Alternatively, TAF4b may play a novel and more
direct role in the regulation of apoptosis. Experiments
discriminating between these diverse molecular mechanisms
are required in the future.
In conclusion, we posit that TAF4b is a prominent integrator
of granulosa cell gene expression programs that are required for
granulosa cell proliferation and survival throughout folliculo-
gensis. These processes are most likely disrupted in the absence
of TAF4b because of pleiotropic defects associated with
interruption of normal development of ovarian follicles. As
the granulosa cell–oocyte interactions falter, follicle growth and
maturation dwindle until severe follicle depletion is observed in
the adult TAF4b-null mice. Why the addition of TAF4b variant
to the canonical TFIID complex changes its transcriptional
output still remains a mystery. TAF4b may bind to cell type-
specific activators and/or ubiquitous activators to generate
granulosa cell-specific gene expression patterns. It also may
bind to other gonadal-enriched members of core transcriptional
regulatory complexes including TFIIA (Xiao et al., 2006).
Alternatively, in combination with its function within TFIID,
TAF4b may function in a TFIID-independent fashion in the
ovary. Perhaps TAF4b is monitoring the signaling or cell cycle
status of granulosa cells and responds to certain cellular events
by incorporation into TFIID complexes to modulate gene
expression patterns accordingly. Further molecular and cellular
dissection of the granulosa cell- and oocyte-specific functionsof TAF4b, and the combination thereof in transcription and
oogenesis is necessary to advance our understanding of
fundamental principles regulating female reproductive devel-
opment in mammals. Such knowledge may have profound
implications for the treatment of ovarian pathologies including
premature ovarian failure and certain subtypes of ovarian
cancers in women.
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